SCOPUS 정보 검색 플랫폼

Volumn 55, Issue 2, 2001, Pages 97-109

On the evaluation of drug benefits policy changes with longitudinal claims data: The policy maker's versus the clinician's perspective

(5) Schneeweiss, Sebastian a,b Maclure, Malcolm a,c Walker, Alexander M a Grootendorst, Paul d,e Soumerai, Stephen B f

a HARVARD SCHOOL OF PUBLIC HEALTH (United States)

b BRIGHAM AND WOMEN S HOSPITAL (United States)

c MINISTRY OF HEALTH (Canada)

d MCMASTER UNIVERSITY (Canada)

e CENTRE FOR EVALUATION OF MEDICINES (Canada)

f HARVARD MEDICAL SCHOOL (United States)

Author keywords

Claims data; Cost control; Evaluation; Health services research; Longitudinal studies; Pharmaceuticals; Selection bias

Indexed keywords

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG THERAPY; EVALUATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; LONGITUDINAL STUDY; MODEL; PATIENT COMPLIANCE;

ATTITUDE OF HEALTH PERSONNEL; COST CONTROL; COST SHARING; GUIDELINE ADHERENCE; HEALTH EXPENDITURES; HEALTH POLICY; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, PHARMACEUTICAL SERVICES; LONGITUDINAL STUDIES; PHYSICIANS; POLICY MAKING; UNITED STATES;

EID: 0035158249 PISSN: 01688510 EISSN: None Source Type: Journal
DOI: 10.1016/S0168-8510(00)00120-2 Document Type: Article

Times cited : (30)

References (29)

1
- 0006510967
- Quasi-Experimentation. Design and Analysis Issues for Field Studies, Boston: Houghton Mifflin
- (1979)
- Cook, T.D.¹ Campbell, D.T.²

2
- 0027351336
- A critical analysis of studies of state drug reimbursement policies: research in need of discipline
- (1993) Milbank Quarterly , vol.71 , pp. 217-252
- Soumerai, S.B.¹ Ross-Degnan, D.² Fortess, E.E.³ Abelson, J.⁴

3
- 0006511407
- Cost-Effectiveness in Health and Medicine, New York: Oxford University Press
- (1996) , pp. 185
- Gold, M.R.¹ Siegel, J.E.² Russell, L.B.³ Weinstein, M.C.⁴

4
- 0029949536
- Can medicalsavings accounts for the nonelderly reduce health care costs
- (1996) Journal of the American Medical Association , vol.275 , pp. 1666-1671
- Keeler, E.B.¹ Malkin, J.D.² Goldman, D.P.³ Buchanan, J.L.⁴

5
- 0022652321
- The assessment of health policy changes using the time-reversed crossover design
- (1986) Health Services Research , vol.20 , pp. 705-736
- Sollecito, W.A.¹ Gillings, D.B.²

6
- 0028061156
- International pharmaceutical spending controls: France, Germany, Sweden and the United Kingdom
- (1994) Health Care Financing Review , vol.15 , pp. 127-140
- Gross, D.J.¹ Ratner, J.² Perez, J.³ Glavin, S.L.⁴

7
- 0006510822
- Ernigh R.C. (Ed.), Novartis Pharmacy Benefit Report: 1998. Trends and Forecast, East Hanover, NJ: Novartis
- (1998)

8
- 0006514597
- Steinhauer J. Rising cost of drugs take a bigger share of health insurance outlays. New York Times, 10/29/99.

9
- 0006608117
- Pharmacare. Antihypertensives: Information on Reference Drug Pricing in British Columbia, 1997.

10
- 0006545243
- British Columbia Pharmacy Association. Position Statement, Reference-based Pricing, Richmond: British Columbia Pharmacy Association, 1996.

11
- 0031038435
- A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada
- (1997) Canadian Journal of Cardiology , vol.13 , pp. 33-38

12
- 0033543069
- Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors
- (1999) Canadian Medical Association Journal , vol.161 , pp. 255-260
- Bourgault, C.¹ Elstein, E.² Le Lorier, J.³ Suissa, S.⁴

13
- 0032488379
- Increased thrombotic vascular events after change of statin
- (1998) Lancet , vol.352 , pp. 1830-1831
- Thomas, M.¹ Mann, J.²

14
- 0032104786
- What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution
- (1998) Health Policy , vol.44 , Issue.3 , pp. 253-260
- Schneeweiss, S.¹ Schöffski, O.² Selke, G.W.³

15
- 0031183742
- Reference-based pricing (RBP) of prescription drugs
- (1997) Canadian Journal of Cardiology , vol.13 , pp. 689-690
- Holbrook, A.¹ O'Brien, B.² Grootendorst, P.³

16
- 0342331290
- National health expenditures in 1997: more slow growth
- (1998) Health Affairs , vol.17 , pp. 99-110
- Levit, K.¹ Cowan, C.² Braden, B.³ Stiller, J.⁴ Sensing, A.⁵ Lazenby, H.⁶

17
- 4244040110
- Drug prescribing, drug taking, adverse reactions, and compliance
- Salzman C. (Ed.), Clinical Geriatric Psychopharmacology, third ed., Baltimore: Wiliams and Wilkins
- (1998)
- Avorn, J.¹

18
- 0002744722
- Principles of pharmacology
- Cassel C.K., Riesenberg D.E., Sorensen L.B., Walsh J.R. (Eds.), Geriatric Medicine, second ed., New York: Springer
- (1990)
- Avorn, J.¹ Gurwitz, J.²

19
- 0028210444
- Why has patient compliance become important
- (1994) Clinical Research and Regulatory Affairs , vol.11 , pp. 81-106
- Urquhart, J.¹

20
- 0006545784
- Clinical Trials. A Methodologic Perspective, New York: Wiley
- (1997)
- Piantadosi, S.¹

21
- 0006568548
- Evaluation of Health Promotion and Education Programs, Mountain View: Mayfield
- (1984) , pp. 129-131
- Windsor, R.A.¹ Baranowski, T.² Clark, N.³ Cutter, G.⁴

22
- 0006574130
- The Economics of Health and Health Care, second ed., Upper Saddle River: Prentice Hall
- (1997)
- Folland, S.¹ Goodman, A.C.² Stano, M.³

23
- 0006546330
- Evaluation and Decision Making for Health Services, second ed., Ann Arbor: Health Administration Press
- (1991) , pp. 233-257
- Veney, J.E.¹ Kaluzny, A.D.²

24
- 0000131609
- Author's reply to compliance, bias, and power in clinical trials
- (1991) Biometrics , vol.47 , pp. 778-779
- Zelen, M.¹

25
- 0006574131
- Effectiveness and Efficiency; Random Reflections on Health Services, London: Nuffield Provincial Hospitals Trust
- (1972)
- Cochrane, A.L.¹

26
- 84949193513
- Reducing bias in observational studies using sub-classification on the propensity score
- (1984) Journal of the American Statistical Association , vol.79 , pp. 516-524
- Rosenbaum, P.R.¹ Rubin, D.B.²

27
- 0001815275
- Causal inference from complex longitudinal data
- Berkane M. (Ed.), Latent Variable Modeling and Applications to Causality. Lecture Notes in Statistics (120), New York: Springer
- (1997) , pp. 69-117
- Robins, J.M.¹

28
- 0033528422
- Thrombotic vascular events after change of statin
- (1999) Lancet , vol.353 , pp. 844
- Weiss, N.¹ Heckbert, S.R.²

29
- 0006570809
- Statistical Issues in Drug Development, Chichester: Wiley
- (1997)
- Senn, S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.